Mycophenolate Mofetil

Overview

Mycophenolate mofetil is an immunosuppressive agent used to prevent organ transplant rejection. It acts by inhibiting the proliferation of activated T and B lymphocytes.

API suppliers (23)

Suppliers of Mycophenolate Mofetil evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD3 active DMF GMP on record
• CONCORD BIOTECH LTDIndia2 active DMF GMP on record
• Chongqing Daxin Pharmaceutical Co., Ltd.China1 active DMF
• JOYANG LABORATORIESChina1 active DMF
• RAKSHIT PHARMACEUTICALS LTD1 active DMF
• DASAMI LAB PRIVATE LTDIndia1 active DMF GMP on record
• Intas Pharmaceuticals Ltd.India1 active DMF GMP on record
• Biocon LimitedIndia1 active DMF
• Shandong New Time Pharmaceutical Co Ltd1 active DMF GMP on record
• Formosa Laboratories, Inc.Taiwan1 active DMF GMP on record
• Wuxi Fortune Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• HISUN PHARMACEUTICAL HANGZHOU CO LTD1 active DMF
• Emcure Pharmaceuticals LimitedIndia1 active DMF GMP on record
• SOLARA ACTIVE PHARMA SCIENCES LTDIndia1 active DMF GMP on record
• LEK PHARMACEUTICALS DD GMP on record
• IVAX PHARMACEUTICALS SRO
• Cipla USA, Inc.USA
• EXCELLA GMBH GMP on record
• HAUDONG MEDICINE CO LTD
• Apotex Pharmachem India Pvt. Ltd.India
• DSM ANTI INFECTIVES BV
• Zhejiang Hisun Pharmaceutical Co., Ltd.China GMP on record
• Rpg Life Sciences Ltd.India GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (38 approved US products), the latest listed US patent on Mycophenolate Mofetil expires 16 Aug 2039. Generic API sourcing typically opens up once these lapse.

Therapeutic areas